Also known as: Circumvent Pharmaceuticals
Utilizing monogenic disorders to inform and solve highly complexβ¦
Company is active
Event Year: 2018
Company is active
Event Year: 2018
Circumvent is pioneering a novel approach within the healthcare sector by leveraging insights derived from monogenic disorders. Their work focuses on applying the understanding of these genetically simple conditions to address and resolve intricate medical challenges. By studying the mechanisms and effects of single-gene mutations, Circumvent aims to unlock new therapeutic strategies and diagnostic tools for a range of complex diseases, ultimately improving patient outcomes and advancing medical knowledge.
Circumvent is pioneering a novel approach within the healthcare sector by leveraging insights derived from monogenic disorders. Their work focuses on applying the understanding of these genetically simple conditions to address and resolve intricate medical challenges. By studying the mechanisms and effects of single-gene mutations, Circumvent aims to unlock new therapeutic strategies and diagnostic tools for a range of complex diseases, ultimately improving patient outcomes and advancing medical knowledge.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2018
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2018
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 6
Hiring: No
Team size: 6
Hiring: No